Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Outset Medical, Inc. (OM)

Compare
10.89
-0.18
(-1.63%)
At close: April 4 at 4:00:02 PM EDT
10.89
0.00
(0.00%)
After hours: April 4 at 4:05:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
113,689
113,689
130,376
115,375
102,602
Cost of Revenue
75,125
75,125
101,376
97,542
94,994
Gross Profit
38,564
38,564
29,000
17,833
7,608
Operating Expense
151,939
151,939
198,770
178,852
138,127
Operating Income
-113,375
-113,375
-169,770
-161,019
-130,519
Net Non Operating Interest Income Expense
-14,110
-14,110
-2,504
-275
-1,217
Other Income Expense
-2,665
--
--
-1,367
--
Pretax Income
-127,485
-127,485
-172,274
-162,661
-131,736
Tax Provision
491
491
523
295
199
Net Income Common Stockholders
-127,976
-127,976
-172,797
-162,956
-131,935
Diluted NI Available to Com Stockholders
-127,976
-127,976
-172,797
-162,956
-131,935
Basic EPS
-2.46
--
-3.48
-3.38
-2.89
Diluted EPS
-2.46
--
-3.48
-3.38
-2.89
Basic Average Shares
51,951
--
49,588
48,161
45,589
Diluted Average Shares
51,951
--
49,588
48,161
45,589
Total Operating Income as Reported
-113,375
-113,375
-169,770
-161,019
-130,519
Total Expenses
227,064
227,064
300,146
276,394
233,121
Net Income from Continuing & Discontinued Operation
-127,976
-127,976
-172,797
-162,956
-131,935
Normalized Income
-127,976
-127,976
-172,797
-161,876.07
-131,935
Interest Income
9,761
9,761
10,171
3,291
498
Interest Expense
23,871
23,871
12,675
3,566
1,715
Net Interest Income
-14,110
-14,110
-2,504
-275
-1,217
EBIT
-103,614
-103,614
-159,599
-159,095
-130,021
EBITDA
-97,886
-97,886
-153,789
-153,926
-124,859
Reconciled Cost of Revenue
75,125
75,125
101,376
97,542
94,994
Reconciled Depreciation
5,728
5,728
5,810
5,169
5,162
Net Income from Continuing Operation Net Minority Interest
-127,976
-127,976
-172,797
-162,956
-131,935
Total Unusual Items Excluding Goodwill
--
--
--
-1,367
--
Total Unusual Items
--
--
--
-1,367
--
Normalized EBITDA
-97,886
-97,886
-153,789
-152,559
-124,859
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
-287.07
--
12/31/2021 - 9/15/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LUNG Pulmonx Corporation
6.76
0.00%
 
MASS 908 Devices Inc.
3.8100
+1.87%
 
TNDM Tandem Diabetes Care, Inc.
16.88
-4.42%
 
RPID Rapid Micro Biosystems, Inc.
2.1900
-14.12%
 
CVRX CVRx, Inc.
11.72
-4.48%
 
PRCT PROCEPT BioRobotics Corporation
51.23
-6.48%
 
SGHT Sight Sciences, Inc.
2.3000
+3.14%
 
TMCI Treace Medical Concepts, Inc.
7.75
-1.02%
 
NVCR NovoCure Limited
16.49
-2.89%
 
GKOS Glaukos Corporation
83.65
-3.85%